RegulatoryJul 24, 2026, 05:31 PM
MDxHealth Receives Nasdaq MVLS Non-Compliance Notice
AI Summary
MDxHealth SA received an additional notice from Nasdaq on July 20, 2026, indicating non-compliance with the $35 million minimum Market Value of Listed Securities (MVLS) requirement. This follows an earlier notice regarding the minimum bid price. The company has been granted a 180-calendar day period, until January 19, 2027, to regain compliance by maintaining an MVLS of at least $35 million for 10 consecutive business days. The notice does not immediately affect the company's Nasdaq listing, and MDxHealth intends to address the deficiency.
Key Highlights
- Received additional Nasdaq notice on July 20, 2026, for MVLS non-compliance.
- Market Value of Listed Securities (MVLS) fell below $35 million minimum requirement.
- MVLS deficiency observed from June 1, 2026, to July 17, 2026.
- Granted 180-calendar day compliance period until January 19, 2027.
- Must maintain MVLS above $35 million for 10 consecutive business days to regain compliance.
- Notice has no immediate effect on Nasdaq listing of ordinary shares.
- Company intends to monitor market value and cure the deficiency.
Price Impact
More from MDXH